For the best management, please ask for assistance!

European Journal of Heart FailureVolume 25, Issue 4 p. 573-575 Invited Editorial For the best management, please ask for assistance! Clément Delmas, Corresponding Author Clément Delmas [email protected] [email protected] Intensive Cardiac Care Unit, Rangueil University Hospital, Toulouse, France REICATRA, Institut Saint Jacques, CHU de Toulouse, Toulouse, France Corresponding author. Intensive Cardiac Care Unit, Rangueil University Hospital, 1 Avenue Jean Poulhes, 31059 Toulouse Cedex, France. Tel: +33 5 61322426/+33 673147951, Email: [email protected], [email protected]Search for more papers by this authorLaurent Bonello, Laurent Bonello Aix-Marseille Université, Marseille, France Intensive Care Unit, Department of Cardiology, Assistance Publique-Hôpitaux de Marseille, Hôpital Nord, Marseille, France Mediterranean Association for Research and Studies in Cardiology (MARS Cardio), Marseille, FranceSearch for more papers by this authorFrançois Roubille, François Roubille PhyMedExp, Université de Montpellier, INSERM, CNRS, Cardiology Department, INI-CRT, CHU de Montpellier, Montpellier, FranceSearch for more papers by this author Clément Delmas, Corresponding Author Clément Delmas [email protected] [email protected] Intensive Cardiac Care Unit, Rangueil University Hospital, Toulouse, France REICATRA, Institut Saint Jacques, CHU de Toulouse, Toulouse, France Corresponding author. Intensive Cardiac Care Unit, Rangueil University Hospital, 1 Avenue Jean Poulhes, 31059 Toulouse Cedex, France. Tel: +33 5 61322426/+33 673147951, Email: [email protected], [email protected]Search for more papers by this authorLaurent Bonello, Laurent Bonello Aix-Marseille Université, Marseille, France Intensive Care Unit, Department of Cardiology, Assistance Publique-Hôpitaux de Marseille, Hôpital Nord, Marseille, France Mediterranean Association for Research and Studies in Cardiology (MARS Cardio), Marseille, FranceSearch for more papers by this authorFrançois Roubille, François Roubille PhyMedExp, Université de Montpellier, INSERM, CNRS, Cardiology Department, INI-CRT, CHU de Montpellier, Montpellier, FranceSearch for more papers by this author First published: 16 March 2023 https://doi.org/10.1002/ejhf.2826 The opinions expressed in this article are not necessarily those of the Editors of the European Journal of Heart Failure or of the European Society of Cardiology. doi: 10.1002/ejhf.2796 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Delmas C, Roubille F, Lamblin N, Bonello L, Leurent G, Levy B, et al. Baseline characteristics, management, and predictors of early mortality in cardiogenic shock: insights from the FRENSHOCK registry. ESC Heart Fail. 2022; 9: 408–19. 2Pappalardo F, Tavazzi G, Savonitto S, Morici N. Enrolling patients in cardiogenic shock trials: are we missing someone? Insights from the Italian AltShock-2 registry. Eur J Heart Fail. 2022; 24: 1748–50. 3Schrage B, Beer BN, Savarese G, Dabboura S, Yan I, Sundermeyer J, et al. Eligibility for mechanical circulatory support devices based on current and past randomised cardiogenic shock trials. Eur J Heart Fail. 2021; 23: 1942–51. 4Brener MI, Rosenblum HR, Burkhoff D. Pathophysiology and advanced hemodynamic assessment of cardiogenic shock. Methodist Debakey Cardiovasc J. 2020; 16: 7–15. 5Thayer KL, Zweck E, Ayouty M, Garan AR, Hernandez-Montfort J, Mahr C, et al. Invasive hemodynamic assessment and classification of in-hospital mortality risk among patients with cardiogenic shock. Circ Heart Fail. 2020; 13:e007099. 6Ostadal P, Rokyta R, Karasek J, Kruger A, Vondrakova D, Janotka M, et al.; ECMO-CS Investigators. Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: results of the ECMO-CS randomized clinical trial. Circulation. 2023; 147: 454–64. 7Banning AS, Adriaenssens T, Berry C, Bogaerts K, Erglis A, Distelmaier K, et al. Veno-arterial extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock: rationale and design of the randomised, multicentre, open-label EURO SHOCK trial. EuroIntervention. 2021; 16: e1227–36. 8 Schrage B, Sundermeyer J, Beer BN, Bertoldi L, Bernhardt A, Blankenberg S, et al. Use of mechanical circulatory support in patients with non-ischaemic cardiogenic shock. Eur J Heart Fail. 2023; 25: 562–72. 9Moonsamy P, Axtell AL, Ibrahim NE, Funamoto M, Tolis G, Lewis GD, et al. Survival after heart transplantation in patients bridged with mechanical circulatory support. J Am Coll Cardiol. 2020; 75: 2892–905. 10Thiele H, Ohman EM, de Waha-Thiele S, Zeymer U, Desch S. Management of cardiogenic shock complicating myocardial infarction: an update 2019. Eur Heart J. 2019; 40: 2671–83. 11den Uil CA, Van Mieghem NM, Bastos MB, Jewbali LS, Lenzen MJ, Engstrom AE, et al. Primary intra-aortic balloon support versus inotropes for decompensated heart failure and low output: a randomised trial. EuroIntervention. 2019; 15: 586–93. 12Henry TD, Yannopoulos D, van Diepen S. Extracorporeal membrane oxygenation for cardiogenic shock: when to open the parachute? Circulation. 2023; 147: 465–8. 13den Uil CA, Jewbali LS, Heeren MJ, Constantinescu AA, Van Mieghem NM, Reis Miranda DD. Isolated left ventricular failure is a predictor of poor outcome in patients receiving veno-arterial extracorporeal membrane oxygenation. Eur J Heart Fail. 2017; 19 Suppl 2: 104–9. 14Schrage B, Sundermeyer J, Blankenberg S, Colson P, Eckner D, Eden M, et al. Timing of active left ventricular unloading in patients on venoarterial extracorporeal membrane oxygenation therapy. JACC Heart Fail. 2023; 11: 321–30. 15Morici N, Marini C, Sacco A, Tavazzi G, Cipriani M, Oliva F, et al.; Altshock-2 Group. Early intra-aortic balloon pump in acute decompensated heart failure complicated by cardiogenic shock: rationale and design of the randomized Altshock-2 trial. Am Heart J. 2021; 233: 39–47. Volume25, Issue4April 2023Pages 573-575 ReferencesRelatedInformation